foxo4 dri senolytic peptide human trial 2024 2025 Frontiers Senolytics: charting a new course
Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Computational design of peptide targeting FOXO4. a, Domains of FOXO4 Download Scientific Diagram Targeting Senescence: A Review of Senolytics and Senomorphics in Anti Aging Interventions Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




